Early channel transurethral resection of the prostate for patients with urinary retention after brachytherapy

作者: You-yun Zhang , Zhi-gen Zhang , Yan-lan Yu , Yi-cheng Chen , Kang-xin Ni

DOI: 10.1631/JZUS.B1400100

关键词: Urinary retentionUrinary systemBrachytherapyTransurethral resection of the prostateUrologyProstate cancerBiochemical recurrenceStage (cooking)Prostate brachytherapyMedicine

摘要: It is recommended that transurethral resection of the prostate (TURP) after brachytherapy should not be performed at an early stage implantation. Herein we report our experiences and results channel TURP (cTURP) within six months post-implant for patients with refractory urinary retention. One hundred ninety localized cancer clinical stages T1c to T2c were treated by as monotherapy institution from February 2009 July 2013. Nine who developed retention underwent cTURP retrospectively reviewed analyzed. The median interval between was three (range 1.5 5.0 months). There no intraoperative or postoperative complications incontinence resulting surgery. All relieved per American Brachytherapy Society symptom score. With a mean follow-up time 16 6 26 months) cTURP, patient experienced biochemical recurrence. serum prostate-specific antigen (PSA) 0.42 ng/ml 0.08 0.83 ng/ml) end their follow-up. Early found safe effective in relieving could without compromising its therapeutic efficacy.

参考文章(21)
IORI SAKAI, KEN-ICHI HARADA, TOSHIFUMI KURAHASHI, KAZUKI YAMANAKA, ISAO HARA, HIDEAKI MIYAKE, Analysis of differences in clinicopathological features between prostate cancers located in the transition and peripheral zones International Journal of Urology. ,vol. 13, pp. 368- 372 ,(2006) , 10.1111/J.1442-2042.2006.01307.X
Yoshimasa Jo, Hiratsuka Junichi, Fujii Tomohiro, Imajo Yoshinari, Fujisawa Masato, Radical prostatectomy versus high-dose rate brachytherapy for prostate cancer: effects on health-related quality of life BJU International. ,vol. 96, pp. 43- 47 ,(2005) , 10.1111/J.1464-410X.2005.05564.X
Willet F. Whitmore, Basil Hilaris, Harry Grabstald, Retropubic Implantation of Iodine 125 in the Treatment of Prostatic Cancer The Journal of Urology. ,vol. 167, pp. 981- 983 ,(1972) , 10.1016/S0022-5347(02)80318-4
Louis Potters, Eric A Klein, Michael W Kattan, Chandana A Reddy, Jay P Ciezki, Alwyn M Reuther, Patrick A Kupelian, None, Monotherapy for stage T1–T2 prostate cancer: radical prostatectomy, external beam radiotherapy, or permanent seed implantation Radiotherapy and Oncology. ,vol. 71, pp. 29- 33 ,(2004) , 10.1016/J.RADONC.2003.12.011
Mark R Storey, Robert C Landgren, Joseph L Cottone, J.Walt Stallings, Charles W Logan, Lacy P Fraiser, Cynthia S Ross, Robert J Kock, Lawrence W Berkley, Martin Hauer-Jensen, Transperineal 125iodine implantation for treatment of clinically localized prostate cancer: 5-year tumor control and morbidity. International Journal of Radiation Oncology Biology Physics. ,vol. 43, pp. 565- 570 ,(1999) , 10.1016/S0360-3016(98)00451-9
Herbert Augustin, Peter G Hammerer, Jakob Blonski, Markus Graefen, Jüri Palisaar, Fedor Daghofer, Hartwig Huland, Andreas Erbersdobler, Zonal location of prostate cancer: significance for disease-free survival after radical prostatectomy? Urology. ,vol. 62, pp. 79- 85 ,(2003) , 10.1016/S0090-4295(03)00248-6
N Stone, Complications following permanent prostate brachytherapy European Urology. ,vol. 41, pp. 427- 433 ,(2002) , 10.1016/S0302-2838(02)00019-2
M.A. KOLLMEIER, R.G. STOCK, J. CESARETTI, N.N. STONE, URINARY MORBIDITY AND INCONTINENCE FOLLOWING TRANSURETHRAL RESECTION OF THE PROSTATE AFTER BRACHYTHERAPY The Journal of Urology. ,vol. 173, pp. 808- 812 ,(2005) , 10.1097/01.JU.0000152698.20487.0E
Alfred W. Mazur, Ian M. Thompson, Efficacy and morbidity of“channel” turp Urology. ,vol. 38, pp. 526- 528 ,(1991) , 10.1016/0090-4295(91)80170-C